Paper12925844
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
Edinger M and 6 others. Nat Med, 2003. Cited by 1,074 papers, by iCite.
Cite this record
ConductScience Library. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Papers, record 12925844. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12925844
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Marrow Transplantation | Major topic |
| Graft vs Host Disease | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| CD4-Positive T-Lymphocytes | |
| CD8-Positive T-Lymphocytes | |
| Cell Survival | |
| Female | |
| Interferon-gamma | |
| Interleukin-2 Receptor alpha Subunit | |
| Leukemia | |
| Lymphoma | |
| Membrane Glycoproteins | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C57BL | |
| Mice, Mutant Strains | |
| Perforin | |
| Pore Forming Cytotoxic Proteins | |
| Receptors, Interleukin | |
| Receptors, Interleukin-2 | |
| Transplantation, Homologous |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI49903 | NIAID NIH HHS | United States | R21AI049903 | PubMed and NIH | NIH RePORTER |
| CA65237 | NCI NIH HHS | United States | R01CA065237 | PubMed and NIH | NIH RePORTER |
| CA92225 | NCI NIH HHS | United States | R01CA092225 | PubMed and NIH | NIH RePORTER |
| DK61925 | NIDDK NIH HHS | United States | U01DK061925 | PubMed and NIH | NIH RePORTER |
| HL57443 | NHLBI NIH HHS | United States | P01HL057443 | PubMed and NIH | NIH RePORTER |
| HL58520 | NHLBI NIH HHS | United States | R29HL058520 | PubMed and NIH | NIH RePORTER |
| P01-CA49605 | NCI NIH HHS | United States | P01CA049605 | PubMed and NIH | NIH RePORTER |
| R01S CA8006 | NCI NIH HHS | United States | PubMed | PubMed |
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01244906 | Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant | Background | ClinicalTrials.gov | |
| NCT06845592 | Safely Delivered Targeted High-dose Irradiation Followed by Adoptive Immunotherapy with Regulatory and Conventional T Cells to Increase Potency of Hematopoietic Stem Cell Transplantation in High-risk Acute Leukemia | Background | ClinicalTrials.gov | |
| NCT07576699 | CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD) | Background | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 12949524 | Taming transplantation with T cells. | https://conductscience.org/library/papers/12949524 |
Source PubMed
Cited by605
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,074 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42913002 | NAD+ metabolic restoration resolves the inflammation-immunocompetence trade-off in lung graft-versus-host disease. | Sci Adv | 2026 | https://conductscience.org/library/papers/42913002 | PubMed |
| 42851423 | Short term ex vivo graft conditioning with venetoclax, fluticasone propionate, and IL-2 reduces graft versus host disease in mouse allogeneic hematopoietic cell transplantation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42851423 | PubMed |
| 42617044 | CXCR4-dependent migratory differences between peripheral Tregs and Tcons preserve GVL while limiting GVHD after HSCT. | Blood Adv | 2026 | https://conductscience.org/library/papers/42617044 | PubMed |
| 42495148 | Acute gastrointestinal graft-versus-host disease is associated with reductions of secondary bile acids following allogeneic hematopoietic cell transplantation. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42495148 | PubMed |
| 42277051 | Chronic graft-versus-host disease. | Nat Rev Dis Primers | 2026 | https://conductscience.org/library/papers/42277051 | PubMed |
| 42274698 | Mapping Therapeutic Regulatory T Cell Fate with MRI: Current Strategies and Translational Outlook. | Nanomaterials (Basel) | 2026 | https://conductscience.org/library/papers/42274698 | PubMed |
| 42193279 | Lineage-Specific Chimerism Analysis After Allogeneic Hematopoietic Cell Transplantation in Patients with Myeloid Neoplasms: Current Evidence and Considerations in the Post-Transplant Cyclophosphamide Setting. | Biomedicines | 2026 | https://conductscience.org/library/papers/42193279 | PubMed |
| 42122228 | Myeloid Cell-Targeting PLGA Nanoparticles Ameliorate Acute Graft-Versus-Host Disease. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42122228 | PubMed |
| 41979099 | Hybrid Systems Modeling of Donor T-Cell Responses and Graft-Versus-Host-Disease After Posttransplantation Cyclophosphamide Administration. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/41979099 | PubMed |
| 41811903 | CAR-Cell Therapy for Autoimmune Diseases: From the Laboratory to Clinical Practice. | J Immunol Res | 2026 | https://conductscience.org/library/papers/41811903 | PubMed |
| 41799211 | In vivo Expansion of Regulatory T cells via an Engineered IL-2 Mutein to Suppress Autoimmune Glomerulonephritis. | Theranostics | 2026 | https://conductscience.org/library/papers/41799211 | PubMed |
| 41758930 | Regulatory-like FOXP3+Helios+CD4+ T conventional cells correlate with T-cell activation after Orca-T immunotherapy. | Blood | 2026 | https://conductscience.org/library/papers/41758930 | PubMed |
| 41550465 | Low Dose of IL-2 Application for Graft-Versus-Host Disease Prophylaxis Following Haploidentical Stem Cell Transplantation. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/41550465 | PubMed |
| 41521559 | Engineered CD40-biosensor-expressing Treg cells as a cell therapy approach for inflammatory diseases. | Mol Ther | 2026 | https://conductscience.org/library/papers/41521559 | PubMed |
| 41459483 | Development of a humanized mouse model of graft-versus-host disease to assess human regulatory T cell function. | Front Immunol | 2025 | https://conductscience.org/library/papers/41459483 | PubMed |
| 41411147 | Posttransplant cyclophosphamide in HLA-matched peripheral blood transplantation: what's next? | Blood | 2026 | https://conductscience.org/library/papers/41411147 | PubMed |
| 41385341 | Orca-T vs allogeneic hematopoietic stem cell transplantation (Precision-T): a multicenter, randomized phase 3 trial. | Blood | 2026 | https://conductscience.org/library/papers/41385341 | PubMed |
| 41252283 | Allogeneic haematopoietic cell transplantation promotes atherosclerosis in mice via CD8+ T cells. | Cardiovasc Res | 2025 | https://conductscience.org/library/papers/41252283 | PubMed |
| 41172558 | Regulatory T cell approaches for graft-versus-host disease prevention. | Curr Opin Immunol | 2026 | https://conductscience.org/library/papers/41172558 | PubMed |
| 40942043 | BI-5756 Reduces Graft-Versus-Host Disease Through CB1-Mediated Treg Upregulation. | Molecules | 2025 | https://conductscience.org/library/papers/40942043 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12925844
GET https://conductscience.org/api/papers/v1/12925844/cited_by?page=2